Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

38.50
+0.83002.20%
Post-market: 38.900.4000+1.04%19:59 EDT
Volume:1.20M
Turnover:46.61M
Market Cap:3.07B
PE:-10.25
High:39.28
Open:38.03
Low:38.00
Close:37.67
Loading ...

Why Akero Therapeutics Inc. (AKRO) Surged on Monday

Insider Monkey
·
28 Jan

Akero Therapeutics’ Efruxifermin Shows Promise: Buy Rating Backed by Upcoming SYMMETRY Data and Potential Stock Upside

TIPRANKS
·
28 Jan

Akero Therapeutics price target raised to $96 from $46 at Morgan Stanley

TIPRANKS
·
28 Jan

Akero Therapeutics: Promising SYMMETRY Trial Results Position Efruxifermin for Market Success

TIPRANKS
·
28 Jan

Akero Therapeutics Is Maintained at Buy by Citigroup

Dow Jones
·
28 Jan

Akero Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
28 Jan

Akero Therapeutics Inc : Morgan Stanley Raises Target Price to $96.00 From $46.00

THOMSON REUTERS
·
28 Jan

U.S. RESEARCH ROUNDUP-Akero Therapeutics, Coca-Cola, Mastec

Reuters
·
28 Jan

Akero Therapeutics Starts $300 Million Stock Offering

MT Newswires Live
·
28 Jan

BUZZ-89bio slides on stock offering to fund MASH drug

Reuters
·
28 Jan

Akero Therapeutics announces $300M common stock offering

TIPRANKS
·
28 Jan

Akero Therapeutics Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
28 Jan

Akero Therapeutics Inc - Grants Underwriters 30-Day Option for Additional $45 Million Shares

THOMSON REUTERS
·
28 Jan

Akero Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
28 Jan

Akero cirrhosis data positive for Madrigal, says Piper Sandler

TIPRANKS
·
28 Jan

S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher

Benzinga
·
28 Jan

Madrigal dip on Akero data a buying opportunity, says Evercore ISI

TIPRANKS
·
28 Jan

Top Midday Gainers

MT Newswires Live
·
28 Jan

Akero's Stock Skyrockets 112% After Game-Changing Liver Drug Data

GuruFocus.com
·
28 Jan

Efruxifermin’s Breakthrough in Cirrhosis Reversal Fuels Buy Rating for Akero Therapeutics

TIPRANKS
·
28 Jan